Simultaneous determination of six tyrosine kinase inhibitors in human plasma using HPLC-Q-Orbitrap mass spectrometry.

about

Quantitative determination of erlotinib in human serum using competitive enzyme-linked immunosorbent assay.

P2860

Q54111719-7DE519F4-08DD-47EB-A88B-8FC4790FF8F6

P2860

Simultaneous determination of six tyrosine kinase inhibitors in human plasma using HPLC-Q-Orbitrap mass spectrometry.

Item

http://www.wikidata.org/entity/Q54999095

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Simultaneous determination of ...... -Q-Orbitrap mass spectrometry.

@en

Simultaneous determination of ...... -Q-Orbitrap mass spectrometry.

@nl

type

Item

label

Simultaneous determination of ...... -Q-Orbitrap mass spectrometry.

@en

Simultaneous determination of ...... -Q-Orbitrap mass spectrometry.

@nl

prefLabel

Simultaneous determination of ...... -Q-Orbitrap mass spectrometry.

@en

Simultaneous determination of ...... -Q-Orbitrap mass spectrometry.

@nl

P1476

Simultaneous determination of ...... -Q-Orbitrap mass spectrometry.

@en

P2093

Han-Zhou Mou

http://www.w3.org/2001/XMLSchema#string

Hui Li

http://www.w3.org/2001/XMLSchema#string

Jie Zhou

http://www.w3.org/2001/XMLSchema#string

Mao-Wei Ni

http://www.w3.org/2001/XMLSchema#string

Wei Chen

http://www.w3.org/2001/XMLSchema#string

Zhi-Guo Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.

VEGF blocking therapy in the treatment of cancer.

Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation.

Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.

The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature

Discovery of small molecule cancer drugs: successes, challenges and opportunities.

HRMS using a Q-Exactive series mass spectrometer for regulated quantitative bioanalysis: how, when, and why to implement.

Determination of crizotinib in human and mouse plasma by liquid chromatography electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS).

P304

925-935

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/BIO-2017-0031

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28617069

http://www.w3.org/2001/XMLSchema#string

Simultaneous determination of six tyrosine kinase inhibitors in human plasma using HPLC-Q-Orbitrap mass spectrometry.

about

P2860

P2860

Simultaneous determination of six tyrosine kinase inhibitors in human plasma using HPLC-Q-Orbitrap mass spectrometry.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698